Reviews the unique new pharmaceutical agent OraVerse (phentolamine mesylate) for reversal of soft tissue anesthesia. Covers duration of anesthesia following administration of OraVerse, administration protocols, adverse events, mechanisms of action, dosage protocols, costs of administration and clinical trials data. California Dental Board approved CE. AGD PACE National approved CE. Remote self-directed distance learning online dental CE course.
1 Review Hide Reviews Show Reviews
Interesting course; best for pedo and geriatric practices. Never used Oraverse myself but am tempted for some older patients who are at risk for biting their lips and tongue after treatment.